The purine metabolic gene adenosine deaminase (ADA) is expressed at high levels in a well-defined spatiotemporal pattern in the villous epithelium of proximal small intestine. A duodenum-specific enhancer module responsible for this expression pattern has been identified in the second intron of the human ADA gene. It has previously been shown that binding of the factor PDX-1 is essential for function of this enhancer. The studies presented here examine the proposed roles of GATA factors in the enhancer. Site-directed mutagenesis of the enhancer's GATA binding sites crippled enhancer function in 10 lines of transgenic mice, with 9 of the lines demonstrating <1% of normal activity. Detailed studies along the longitudinal axis of mouse small intestine indicate that GATA-4 and GATA-5 mRNA levels display a reciprocal pattern, with low levels of GATA-6 throughout. Interestingly, gel shift studies with duodenal nuclear extracts showed binding only by GATA-4.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00483.2002DOI Listing

Publication Analysis

Top Keywords

duodenum-specific enhancer
8
gata binding
8
binding sites
8
enhancer
5
high-level activation
4
activation duodenum-specific
4
enhancer requires
4
requires functional
4
functional gata
4
sites purine
4

Similar Publications

Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.

Nat Med

May 2015

1] Toronto General Research Institute and Department of Medicine, University Health Network, Toronto, Ontario, Canada. [2] Department of Physiology, University of Toronto, Toronto, Ontario, Canada. [3] Department of Medicine, University of Toronto, Toronto, Ontario, Canada. [4] Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada.

Resveratrol improves insulin sensitivity and lowers hepatic glucose production (HGP) in rat models of obesity and diabetes, but the underlying mechanisms for these antidiabetic effects remain elusive. One process that is considered a key feature of resveratrol action is the activation of the nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase sirtuin 1 (SIRT1) in various tissues. However, the low bioavailability of resveratrol raises questions about whether the antidiabetic effects of oral resveratrol can act directly on these tissues.

View Article and Find Full Text PDF

Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system.

Mol Pharm

February 2015

Key Laboratory of Drug Targeting, Ministry of Education, Sichuan University, No. 17. Section 3, Southern Renmin Road, Chengdu 610041, People's Republic of China.

Article Synopsis
  • A novel phospholipid complex-based self-nanoemulsifying drug delivery system (PLC-SNEDDS) was designed to enhance the oral absorption of drugs that struggle with solubility and permeability issues.
  • The study focused on morin, a BCS class IV drug and P-glycoprotein (P-gp) substrate, demonstrating that PLC-SNEDDS enhanced morin's intestinal permeability across all segments, shifting absorption from the colon to the ileum.
  • Results indicated that PLC-SNEDDS utilizes cholesterol-dependent pathways for cell uptake, showing low cytotoxicity and improved delivery efficiency, suggesting a promising strategy for delivering poorly absorbed pharmaceuticals.
View Article and Find Full Text PDF

A novel microsphere with a three-layer structure for duodenum-specific drug delivery.

Int J Pharm

July 2011

Key Laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, Sichuan, PR China.

Owing to the quick elimination of drug from duodenum and the depth of Helicobacter pylori (H. pylori) colonized in mucus, antibiotic therapy often fails in the eradication of H. pylori infection for duodenal ulcer.

View Article and Find Full Text PDF

Reexamination of the Akp3(-/-) mouse intestine showed that, despite the lack of intestinal alkaline phosphatase (IAP), the Akp3(-/-) gut still had considerable alkaline phosphatase (AP) activity in the duodenum and ileum. This activity is due to the expression of a novel murine Akp6 gene that encodes an IAP isozyme expressed in the gut in a global manner (gIAP) as opposed to duodenum-specific IAP (dIAP) isozyme encoded by the Akp3 gene. Phylogenetically, gIAP is similar to the rat IAP I isozyme.

View Article and Find Full Text PDF

An intestine-specific gene regulatory region was previously identified near the second exon of the human adenosine deaminase (ADA) gene. In mammalian intestine, ADA is expressed at high levels only along the villi of the duodenal epithelium, principally if not exclusively in enterocytes. Within the ADA intestinal regulatory region, a potent duodenum-specific enhancer was identified that controls this pattern of expression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!